Accendra Health (STU:6OM) E10: €-1.98 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:6OM Accendra Health Inc STU:6OM
59 GF Score
Price €3.14
GF Value €4.74
! 7 Warning Signs
View Full Analysis

What is Accendra Health E10?

Accendra Health STU:6OM +6.08% 59 E10 is €-1.98 as of Mar. 2026. GuruFocus rates STU:6OM with a GF Score™ of 59/100 and a GF Value™ of €4.74. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Accendra Health's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.069. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1.98 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Accendra Health was 30.10% per year. The lowest was -43.60% per year. And the median was 11.20% per year.

As of today (2026-07-15), Accendra Health's current stock price is €3.14. Accendra Health's E10 for the quarter that ended in Mar. 2026 was €-1.98. Accendra Health's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Accendra Health was 395.86. The lowest was 3.36. And the median was 21.48.


Accendra Health  (STU:6OM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Accendra Health was 395.86. The lowest was 3.36. And the median was 21.48.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Accendra Health E10 Related Terms


Accendra Health E10 Historical Data

* Premium members only.

The historical data trend for Accendra Health's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accendra Health E10 Chart

Accendra Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.31 0.06 -0.51 -1.84

Accendra Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.56 -1.49 -1.70 -1.84 -1.98

STU:6OM vs FOCL, YI, COSM: E10 Comparison

For the Medical Distribution subindustry, Accendra Health's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accendra Health Shiller PE Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Accendra Health's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Accendra Health's Shiller PE Ratio falls into.


STU:6OM
59GF Score
Accendra Health Inc STU:6OM
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accendra Health E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Accendra Health's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.069/330.2130*330.2130
=-0.069

Current CPI (Mar. 2026) = 330.2130.

Accendra Health Quarterly Data

per share eps CPI Adj_EPS
201606 0.401 241.018 0.549
201609 0.428 241.428 0.585
201612 0.427 241.432 0.584
201703 0.290 243.801 0.393
201706 0.294 244.955 0.396
201709 0.151 246.819 0.202
201712 0.321 246.524 0.430
201803 0.105 249.554 0.139
201806 -2.628 251.989 -3.444
201809 -0.009 252.439 -0.012
201812 -3.841 251.233 -5.048
201903 -0.204 254.202 -0.265
201906 -0.150 256.143 -0.193
201909 0.018 256.759 0.023
201912 -0.585 256.974 -0.752
202003 -0.172 258.115 -0.220
202006 -0.808 257.797 -1.035
202009 0.645 260.280 0.818
202012 0.592 260.474 0.751
202103 0.823 264.877 1.026
202106 0.722 271.696 0.878
202109 0.493 274.310 0.593
202112 0.487 278.802 0.577
202203 0.472 287.504 0.542
202206 0.350 296.311 0.390
202209 0.162 296.808 0.180
202212 -0.727 296.797 -0.809
202303 -0.299 301.836 -0.327
202306 -0.342 305.109 -0.370
202309 -0.075 307.789 -0.080
202312 0.211 306.746 0.227
202403 -0.267 312.332 -0.282
202406 -0.390 314.175 -0.410
202409 -0.153 315.301 -0.160
202412 -3.667 315.605 -3.837
202503 -0.296 319.799 -0.306
202506 -9.797 322.561 -10.029
202509 -1.653 324.800 -1.681
202512 -0.623 324.054 -0.635
202603 -0.069 330.213 -0.069

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-1.98 mean?
Accendra Health (STU:6OM) has a E10 of €-1.98 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Accendra Health and its competitors.
Is Accendra Health's E10 too high?
Accendra Health's current E10 is €-1.98. Overall, Accendra Health has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's E10 compare to FOCL and YI?
Accendra Health's E10 of €-1.98 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Distribution company?
A good E10 depends on the Medical Distribution industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Accendra Health and its competitors. Accendra Health's current E10 is €-1.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Accendra Health (STU:6OM) has a current E10 of €-1.98. The stock's GF Value™ is €4.74, compared to a current price of €3.14 — trading 33.8% below its estimated fair value. The current E10 is €-1.98. Accendra Health's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Accendra Health (STU:6OM), the current E10 is €-1.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Accendra Health (STU:6OM) Overvalued in 2026?

Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued. The current stock price of €3.14 is trading 33.8% below its estimated GF Value™ of €4.74.

Key valuation signals for STU:6OM:

  • E10: €-1.98
  • GF Value™: €4.74 vs. price of €3.14 (33.8% below fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the STU:6OM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Accendra Health Business Description

Other Exchanges ACH:USA
Address 10900 Nuckols Road, Suite 400, Glen Allen, VA, USA, 23060
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
59GF Score

Get the complete analysis for STU:6OM

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.14
Price
€4.74
GF Value